Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
-
Weekly shot could free patients from daily calcium pills
Disease control CompletedThis study tested a new weekly injection called MBX 2109 for adults with hypoparathyroidism, a condition where the body struggles to control calcium levels. The goal was to see if this hormone replacement could safely maintain normal calcium without requiring high doses of daily …
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
First human test for new drug in kidney patients
Knowledge-focused CompletedThis early-stage study aimed to understand how a new drug, MBX 2109, behaves in the body and how safe it is. It involved 25 adults, some with healthy kidneys and some with varying degrees of kidney impairment. Each participant received a single injection of the drug so researcher…
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Knowledge-focused
Last updated Apr 02, 2026 05:42 UTC